Qube Research & Technologies (QRT)’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Qube Research & Technologies (QRT)'s IBB Position: Q2 2026 in Review
Qube Research & Technologies (QRT) increased its iShares Biotechnology ETF (IBB) stake by 576% in Q2 2026, buying an estimated $6.92M and bringing the position to 47,278 shares worth $8.99M. The position accounts for 0.01% of the portfolio, ranked #1345.
Qube Research & Technologies (QRT) first reported a position in IBB in Q2 2020 and has held it in 16 quarters since. The position peaked at $63.7M in Q3 2021. 955 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Qube Research & Technologies (QRT) held 47,278 shares of iShares Biotechnology ETF worth $8.99M as of Q2 2026.
- Qube Research & Technologies (QRT) bought 40,281 iShares Biotechnology ETF shares in Q2 2026, an estimated $6.92M.
- iShares Biotechnology ETF made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1345 holding.
- Qube Research & Technologies (QRT) first reported a position in iShares Biotechnology ETF in Q2 2020 and has held it in 16 quarters since.
- Qube Research & Technologies (QRT)'s iShares Biotechnology ETF position peaked at $63.7M in Q3 2021.
- 955 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.